Financials
Financial year 2025
AlphaCare from Grez-Doiceau, company number BE0639991647, closed financial year 2025 with a result of € 141,361 after tax. For that financial year AlphaCare recorded a gross margin of € 255,089 and equity of € 485,934. Compared with financial year 2024, the result moved from € 156,142 to € 141,361. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 2, 2025.
€ 485,934
▲ 41% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 141,361
▼ 9% vs 2024
Profit after tax over the fiscal year.
€ 398,565
▲ 210% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 467,334.
People and assets in 2025
€ 53,766
▲ 24% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 13,971
▼ 29% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 2,953
▼ 75% vs 2024
Loans from banks and other lenders, long and short.
€ 26,831
▼ 50% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 34,030
▼ 1% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 231,398 | € 291,679 | € 282,673 | € 255,089 | ▼ 10% |
| Profit after taxes | € 141,959 | € 167,971 | € 156,142 | € 141,361 | ▼ 9% |
| Equity | € 562,778 | € 401,313 | € 344,572 | € 485,934 | ▲ 41% |
| Total debts | € 46,755 | € 84,369 | € 320,187 | € 73,623 | ▼ 77% |
| Cash | € 522,678 | € 339,629 | € 128,455 | € 398,565 | ▲ 210% |
| Retained profit | € 544,178 | € 382,713 | € 325,972 | € 467,334 | ▲ 43% |
| Dividend | € 0 | € 329,435 | € 212,882 | € 0 | ▼ 100% |
| Bank debt | € 0 | € 20,263 | € 11,695 | € 2,953 | ▼ 75% |
| Balance sheet total | € 609,532 | € 485,682 | € 664,760 | € 559,557 | ▼ 16% |
By gross margin, AlphaCare ranks 29th of 59 companies with main activity “Groothandel in farmaceutische en medische artikelen” in Walloon Brabant that publish figures (fiscal year 2025).
Key figures of AlphaCare, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
Ask about AlphaCare the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to AlphaCare?
What happened at AlphaCare in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 141,361 (▼ 9% vs 2024). Source: NBB ↗
- Mathieu de Ribaucourt became a director. NBB
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Drogenbos. KBO
In short
From € 141,959 profit in 2022 to € 141,361 profit in 2025.
Paid € 262,168 in corporate taxes since 2022.
Best year ever: 2023, with € 167,971 profit.
Paid out € 542,318 in dividends to the owners in total.
Management
Behind AlphaCare is Mathieu de Ribaucourt.
Directors
According to the 2025 annual accounts
Mathieu de Ribaucourt
Director
since 2023
Establishments
Establishment units
Physical locations of this company
Rue Constant Wauters 104
1390 Grez-Doiceau
Humaniteitslaan 239
1620 Drogenbos
Active since 6 October 2015
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Walloon Brabant
Same main activity (Groothandel in farmaceutische en medische artikelen), 95 active companies in Walloon Brabant, largest first.
€ 265.6 million revenue · 2025 · Wavre
GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline
€ 241.2 million revenue · 2025 · Wavre
€ 228.3 million revenue · 2026 · Braine-l'Alleud
€ 105.6 million revenue · 2025 · Wavre
€ 74.3 million revenue · 2025 · Ottignies-Louvain-la-Neuve
€ 56.4 million revenue · 2025 · Rixensart
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- CHRISTŸN Comte de RIBAUCOURT Mathieu Emile Jean-Pierre(oprichter) 50%
- CYPRES Pierre Simon René(oprichter) 50%
Details
- Company number
- 0639.991.647
- VAT number
- BE 0639.991.647
- Registered office
- Rue Constant Wauters 104, 1390 Grez-Doiceau
- Names & denominations
- AlphaCare
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 6 October 2015
- Peppol
- Active · Active since 11 Dec 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Handelsbemiddeling in de niet-gespecialiseerde groothandel